Impact of Comorbidities on the First bDMARD Effectiveness and Retention Rate After 2 Years of Follow-up in Patients with Rheumatoid Arthritis. Data from the Spanish Registry BIOBADASER
16/11/2023
López Medina C, Calvo J, Otero-Valera L, Escudero Contreras A, Ortega Castro R, Ladehesa Pineda L, Campos C, Bernabeu-Gonzálvez P, Bohorquez C, Garcia Dorta A, Ruiz-Montesinos D, Pombo Suarez M, Ros I, Alonso F, Castrejon I.
ACR 2023
López Medina C, Calvo J, Otero-Valera L, Escudero Contreras A, Ortega Castro R, Ladehesa Pineda L, Campos C, Bernabeu-Gonzálvez P, Bohorquez C, Garcia Dorta A, Ruiz-Montesinos D, Pombo Suarez M, Ros I, Alonso F, Castrejon I. Impact of Comorbidities on the First bDMARD Effectiveness and Retention Rate After 2 Years of Follow-up in Patients with Rheumatoid Arthritis. Data from the Spanish Registry BIOBADASER [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/impact-of-comorbidities-on-the-first-bdmard-effectiveness-and-retention-rate-after-2-years-of-follow-up-in-patients-with-rheumatoid-arthritis-data-from-the-spanish-registry-biobadaser/
https://acrabstracts.org/abstract/impact-of-comorbidities-on-the-first-bdmard-effectiveness-and-retention-rate-after-2-years-of-follow-up-in-patients-with-rheumatoid-arthritis-data-from-the-spanish-registry-biobadaser/